Seung-kook Park, CEO of HanAll Biopharma Awarded of the President’s Citation on the Science Day
Seung-kook Park, CEO of HanAll Biopharma Awarded of the President’s Citation on the Science Day
HanAll Biopharma Selected as Top 10 Science News of the Year
HanAll Biopharma Selected as Top 10 Science News of the Year
HanAll Biopharma Awarded the Prime Minister’s Citation at the Korea New Growth Management Awards
HanAll Biopharma Awarded the Prime Minister’s Citation at the Korea New Growth Management Awards
HanAll Biopharma has successfully transferred the technology of new antibody drug for autoimmune disease to a foreign company
HanAll Biopharma has successfully transferred the technology of new antibody drug for autoimmune dis..
HanAll Biopharma and Harbour BioMed Sign Collaboration and License Agreement to Develop Two Novel Biologic Therapies in Greater China
HanAll Biopharma and Harbour BioMed Sign Collaboration and License Agreement to Develop Two Novel Bi..
HanAll Biopharma, Approved for Clinical Trial Phase 1 of HL036, New Medicine for Dry Eye Disease
HanAll Biopharma, Approved for Clinical Trial Phase 1 of HL036, New Medicine for Dry Eye Disease